Vanda Pharmaceuticals Inc.VNDANASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-3.11%
↓ 120% below average
Average (9y)
15.86%
Historical baseline
Range
High:51.56%
Low:-10.43%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -3.11% |
| 2023 | -10.43% |
| 2022 | 13.81% |
| 2021 | 35.60% |
| 2020 | 14.24% |
| 2019 | 11.60% |
| 2018 | 13.09% |
| 2017 | 32.21% |
| 2016 | 0.04% |
| 2015 | 51.56% |